The scientific focus adapted
to express the optimum potential
of your molecule

Unparalleled vision in metabolic disorders and risk assessment expertise for post-marketing studies and drug repositioning.

HeartArteryMacrophageLiverMusclePancreasAdipose Tissue

Preclinical development:
In-house predictive models and tracer technologies enable the generation of Proof of Concept efficacy data for your drugs.

Screening and lead validation utilize a dedicated research platform which combine with our focused scientific vision.


Physiogenex is a preclinical contract research organization (CRO) that offers outstanding consultancy and research services, specializing in metabolic disorders such as diabetes, obesity, liver diseases (NASH), dyslipidemia, atherosclerosis and cardiovascular complications.

More than just a CRO, we are your R&D partner of choice to target your specific needs. Our models and technologies are customized and we deliver unparalleled scientific expertise for R&D, preclinical development, post-marketing studies and drug repositioning. We also offer in vivo preclinical imaging services.

We provide both the biopharmaceutical and nutraceutical companies with optimal and reliable solutions for successful strategic decision-making.

R&D, Preclinical and Post marketing studies

Insulin resistance

Hepatic steatosis
to fibrosis




Animal models
from basic to predictive
in-house models

Experimental platform
From gold-standard to innovative assays

Scientific expertise and translational vision